The mythbuster: Is Donald Trump right?
By 
Steve Black2025-08-18T04:25:00
As drug costs soar and the pressure from pharma to speed the introduction of new medicines intensifies, the NHS must navigate complex trade-offs between innovation, affordability, and public health
Register with hsj.co.uk to read the rest of this article
Critical stories remain free for registered users
Certain articles and Insight pieces remain paying-subscriber only content
As a registered user you will get access to:
- Daily News: an essential email round-up of all the latest news, comment and best practice
- Breaking news headlines delivered directly to your inbox
- Limited access to hsj.co.uk
Already registered to HSJ? Sign in now